...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>British journal of neurosurgery >Subdural haematoma complicating shunting for normal pressure hydrocephalus in the setting of concomitant antiplatelet medication - a report of 11 cases
【24h】

Subdural haematoma complicating shunting for normal pressure hydrocephalus in the setting of concomitant antiplatelet medication - a report of 11 cases

机译：硬膜下血肿并发常压脑积水并发抗血小板药-附11例报道

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: To report on the occurrence and management of subdural haematoma after shunt implantation for normal pressure hydrocephalus and to determine the risk of recurrence in the setting of antiplatelet medication. Methods: From a consecutive series of 80 patients implanted with a cerebrospinal fluid shunt for normal pressure hydrocephalus, records from 11 patients taking antiplatelet drugs, who subsequently had surgery for subdural haematoma were extracted and retrospectively reviewed. Results: Patients were followed up for a mean of 1819 days after shunt implantation. Subdural haematomas occurred at a median of 335 days after shunt implantation - four ipsilateral, five contralateral and two bilateral with respect to the ventricular catheter. Three patients had reoperations done within a week without having resumed anti platelet medication in the interim. One of them had three further reoperations done before the subdural collection disappeared. Only one patient had a late recurrence almost 11 years after shunt implantation. Conclusions: Subdural haematoma in the setting of a ventriculoperitoneal implantation for normal pressure hydrocephalus and concomitant antiplatelet medication can be managed along usual lines. Antiplatelet medication can be recommenced in due course with a low risk of recurrence.
机译：目的：报道常压性脑积水分流植入后硬膜下血肿的发生和处理，并确定在抗血小板药物治疗中复发的风险。方法：从连续80例行脑脊液分流术治疗常压性脑积水的患者中，提取11例接受抗血小板药物治疗并随后接受硬膜下血肿手术的患者的记录，并进行回顾性回顾。结果：分流植入后平均随访1819天。硬膜下血肿发生在分流植入后335天的中位数-相对于心室导管，有4个同侧，5个对侧和2个双侧。 3名患者在一周内进行了再次手术，而在此期间未恢复抗血小板药物治疗。其中一名在硬膜下集合消失之前进行了三次再次手术。分流植入后将近11年，只有一名患者复发复发。结论：硬膜下血肿在常压性脑积水的脑室腹膜植入术中并用抗血小板药物可以按照常规方法进行管理。可以在适当的时候推荐抗血小板药物，复发风险低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号